[-] Show simple item record

dc.contributor.authorNelson, Carrie
dc.contributor.authorHitchcock, Kristin
dc.contributor.authorBohlen, James A.
dc.date.issued2009-12eng
dc.description.abstractNo studies directly compare low-density lipoprotein (LDL) levels <70 mg/dL to levels of 71 to 100 mg/dL in very-high-risk patients. However, no evidence suggests a “floor” for LDL cholesterol levels beyond which further reductions of heart disease risk can't be achieved (strength of recommendation [SOR]: A, systematic reviews of randomized controlled trials [RCTs]). The target LDL cholesterol of <70 mg/dL is based on data extrapolated from RCTs (SOR: B).en
dc.identifier.citationJournal of Family Practice, 58(12) 2009: 665-667.en
dc.identifier.urihttp://hdl.handle.net/10355/4005
dc.publisherFamily Physicians Inquiries Networken
dc.relation.ispartofClinical Inquiries, 2009 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subjectcoronary artery diseaseen
dc.subjectstatin therapyen
dc.subjectcholesterolen
dc.subject.lcshCoronary heart disease -- Preventionen
dc.subject.lcshLow density lipoproteinsen
dc.subject.lcshStatins (Cardiovascular agents) -- Effectivenessen
dc.titleWhat does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?en
dc.typeArticleen


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record